Having observed the CpG island hypermethylation-associated silencing of DERL3 in colorectal cancer cells, we then assayed the ability of DERL3 to function as a suppressor of tumour growth, using in vitro and in vivo approaches. Here, DERL3 is linked to neoplasm.